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CHAPTER 5

Political Campaigning: Where Scientific and Ethical
Arguments Meet Public Policy
Emily Mcivor
Science Policy Advisor, People for the Ethical Treatment of Animals
(PETA). London, United Kingdom

1

Introduction

The ambition of the paradigm shift we seek is vast, and the obstacles we face
are intractable. For anyone opposing the use of non-human animals (herein
after referred to as animals) in research and testing, the story has been the
same from the start. Legitimate concern for animals has been all-too-easily
dismissed as misguided sentimentality, and powerful vested interests have
claimed scientific, economic, and moral superiority. But the ground is shifting.
Animal researchers accept the need to provide scientific justification for their
choices, and the protection of animals is increasingly recognized as a public
good. Concern among citizens has been translated into hard-and-fast rules,
and scientific advances have added weight to the growing demand for change.
In deciding how best to achieve the paradigm shift, the question for animal
advocates is how to create the greatest change in the shortest time possible.
This chapter deals with political campaigning at the European Union (Eu)
level, since the adoption of the first Eu Directive on the protection of animals
used for scientific purposes, and focuses on the main political developments
of the past two decades. Historically, much was made of a perceived choice
between presenting ethical or scientific arguments; both are powerful drivers,
providing evidence that existing practice is flawed. Other chapters in this Vol
ume describe aspects of those approaches in detail; similarly, the question of
whether to focus on the 3Rs or replacement only is also covered elsewhere. In
this chapter, a pragmatic policy focus is necessary to explore how scientific
and ethical objectives can be pursued in order to move forward in the politi
cal arena, making full use of existing structures and creating new opportuni
ties. The stakes are high. Our vision requires a revolution in science and in the
way animals are treated. Twenty-first century technology should not depend
on inhumane practices, just as modern economies should not depend on the
destruction of the environment or the exploitation of workers.
© EMILYMCIVOR, 2019
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Before proposing future strategies, it is useful to reflect briefly on the cur
rent situation. In the EU, Directive 2010/63/EU requires Member States to
apply the 3Rs and encourages the further development of new 3R methods
and techniques. Research funding programs identify the replacement of an
imal models as scientific and policy objectives; and several publicly funded
national centers are now dedicated to developing, validating, and promoting
alternative methods. The EU Reference Laboratory for Alternatives to Ani
mal Testing, the European Centre for the Validation of Alternative Methods
(EURL-ECVAM) has, among its duties and tasks, the remit to coordinate and
promote the development and use of alternatives to procedures in the areas
of basic and applied research and regulatory testing (European Parliament,
2010, Directive 2010/63/EU, Annexvn). Each of these achievements has come
about because of pressure from citizens and animal advocacy organizations,
and each has created a momentum of its own so that further progress is inevi
table. At the same time, the number of animals used in scientific procedures
in the EU appears to be increasing (Taylor and Rego, 2016); and animal use is
robustly defended by powerful commercial, academic, and charitable organi
zations. It is legal to restrain conscious non-human primates (NHPs), so they
are unable to move at all for long periods, and to poison animals to death by
applying toxic chemicals to their skin. The scientific revolution is undoubtedly
underway, and Directive 2010/63/EU identifies animal welfare as a "value of
the Union" (European Parliament, 2010, Recital 2); but current practice has not
caught up.

2

The Politics of Animal Experimentation: An Overview

The development of current European regulatory frameworks can be seen as
the culmination of a series of historical confrontations between animal us
ers and advocates (Lyons, 2011). By identifying five "critical junctures", includ
ing the adoption of the United Kingdom's Cruelty to Animals Act in 1876, the
Royal Commission of 1912, and the adoption of the Animals (Scientific Proce
dures) Act in 1986 (UK's transposition of Directive 1986/609 EEc; Council of the
European Communities, 1986), Lyons (2011) traces the evolution, from a largely
self-regulating, animal user community to the current regulatory regime. The
relevance to our situation is the analysis of power exercised by those who de
fend animal use. Through early critical junctures, the power to decide whether
animal use is justified, to control access to information, and to entrench an es
tablishment view that the use of animals is essential to medical progress, was
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firmly placed in the hands of animal users. Only later, with adoption of the
1986 Act, did the necessity for greater public and political scrutiny gain broad
support.
Lyons describes key elements of various positions held, including this anal
ysis of an animal use ideology (2011, pp. 360-361):
- It claims that animal welfare is secondary to research goals
- It considers animal experimentation necessary, and hence permissible,
in the pursuit of knowledge without immediate or foreseeable human
benefit
- It is opposed to utilitarian scrutiny of experimentation proposals
- It supports professional self-regulation and opposes lay interference in animal experimentation.
This is contrasted with an animal welfare belief system:
- It believes that animal welfare should be given significant weight in policy
making
- It believes that proposals for harmful uses of animals should be subject to
independent utilitarian analysis
- It considers animal experimentation necessary, and hence permissible, only
to satisfy urgent and pressing human needs
- It supports the requirement of lay control to ensure consideration of wider
public and animal interests.
And an animal rights philosophy:
- It posits that all sentient animals have inherent value and share human in
terest in avoiding suffering
- It claims that the fundamental rights of protection from torture, killing, and
enslavement should, therefore, extend beyond the human species to other
sentient animals
- It argues for the abolition of animal experimentation.
In the political arena, the welfare belief system often achieves consensus, and
politicians can usually gain majority support for measures appearing to bal
ance competing interests. Furthermore, a welfare agenda represents valuable
middle-ground when the positions of different interest groups seem so far
apart as to be irreconcilable.
Efforts to create a level playing field between industry and civil society
groups have proved effective at the EU level (Persson, 2007); but in terms of
numbers alone, leaving aside financial resources, industry and animal user
groups are better represented than animal advocacy organizations. The
UK Home Office public consultation on the European Commission's (Ee)
proposal to revise Directive 86/609/EEC received only 19 responses from animal
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welfare organizations out of a total of 87 submissions, including 33 from
academic institutions and 17 from representative bodies (Home Office,
2010). An associated imbalance, concerning access to scientific and politi
cal decision makers (Lyons, 2011), again risks leaving animal advocacy orga
nizations severely outdone. However, public opinion is also an important
element of the debate, and animal advocacy organizations have been effec
tive in demonstrating that public concern for animals must be taken into
consideration.
Polling commissioned by the European Coalition to End Animal Experi
ments (ECEAE) on the revision of Directive 86/609/EEC-conducted by
YouGov (2009) in the UK, France, Germany, Italy, Sweden and the Czech
Republic-found that public opinion was not consistent with the EC's legisla
tive proposal; for example, substantial majorities in all countries surveyed fa
vored a ban on experiments causing pain or suffering to NHPs (House of Lords,
2009). UK Government surveys exploring attitudes to animal research (Clem
ence and Leaman, 2016; Leaman, Latter and Clemence, 2014) note varying de
grees of public support or opposition, depending on the phrasing of questions.
There was a slight increase, between 2014 and 20161 in respondents who sup
ported a ban on the use of any animals in research, from 23% to 26%. The 2016
survey also found that 59% of people disagreed with the statement "it does not
bother me if animals are used in scientific research", showing concern for ani
mals among a clear majority of respondents. The difference, in policy terms,
between the abolitionist view (represented by the UK's 26%) and a gradualist
approach is significant; but there is strong agreement (74% of respondents)
with the statement that more work is needed on alternatives to using animals
in scientific research.
In terms of the wider political debate, even though detailed discussions
about animal care and use tend to emphasize differences among stakeholder
organizations rather than areas of agreement, promoting the replacement of
animal procedures is compatible with all three of the belief systems identified
above. Arguing for the increased uptake of human biology-based technologies
in biomedical research is not new; but in an era of rapidly developing science
and divergent opinion concerning other aspects of the debate, its importance
cannot be overestimated. Because of the need for policy makers to arbitrate
between opposing views, and the broad appeal of the alternatives' message,
a major benefit of effective political lobbying is, therefore, ensuring that the
replacement of animal procedures is promoted to the greatest extent possible.
This cannot come at the expense of trying to improve conditions for the ani
mals that are used, but it is a powerful driver towards achieving the paradigm
shift.
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Directive 2010/63/EU

The adoption of EU legislation provides multiple access points, and the EC
encourages interest group participation in order to meet the objective of
connecting the EU more closely to citizens (Persson, 2007). This objective
was amply demonstrated during the lengthy process through which Directive
1986/609/EEC was revised and Directive 2010/63/EU came into being. While
the revision was underway, the EC adopted an Interinstitutional Agreement on
Better Law-making (European Commission, 2003, 2003/C321/01), strengthening
pre-legislative consultation processes and requiring impact assessments. These
access points, while often appearing to delay the process, ensured valuable evi
dence was gathered, informing both the legislative proposal and further po
litical negotiations. Studies, including the scientific Opinion by the European
Food Safety Authority's Animal Health and Animal Welfare Panel (AHAw), and
findings from the Technical Expert Working Group convened by the Ec, cre
ated useful evidence and opportunities for further interventions the following
years.
The legislative proposal-when finally published in 2008-irritated those
defending animal use and, although representing a considerable improvement
on previous legislation, it also failed to satisfy animal advocates. The UK animal
user community, coming together under the auspices of joint Bioscience Sector
position papers, identified several areas of concern, including the proposal to
protect certain invertebrate species, limits on use of NHPs, and burdensome
bureaucracy. The organizations also raised concerns that the draft Directive
would undermine UK and European competitiveness, noting that "As well as
problems with the content, the wording throughout the Directive requires sig
nificant review for scientific accuracy and internal consistency" (Bioscience
Sector, 2009, p. 2). While generally supporting the application of the 3Rs, the
groups opposed creation of national structures to assist in the validation of
new 3R methods, claiming that: "The proposals for National Reference Labora
tories are unnecessary and infeasible and would not be effective at developing
alternative methods. They would divert research funding away from research
which might not only develop alternatives but further benefit biomedical dis
coveries" (Bioscience Sector, 2009, p. 39).
But by the end of the political negotiation, the new legislation, Directive
2010/63/EU, included a handful of promising elements, alongside several mea
sures that are weaker in terms of animal protection, than those contained in
the EC's original proposal. Central to the achievements for animal protection
lobbyists is Recital 10 (European Parliament, 2010), which specifies that "this
Directive represents an important step towards achieving the final goal of full
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replacement of procedures on live animals for scientific and educational pur
poses as soon as it is scientifically possible to do so." In response to proactive
EU-wide campaigning for greater prominence to the replacement of animal
experiments and for the inclusion of basic and applied animal research in the
remit of EURL ECVAM, EU Member States are now required to promote de
velopment and use of alternatives, establish a single contact point to receive
information about new methods, join an EU-wide network of contact points,
and require new projects to be authorized only when alternatives have been
considered. Campaigns to ensure regular "thematic reviews" on areas, such as
the replacement of experiments on NHPs, were partially successful (Article 58);
and Recital 10 states that the Directive should be "reviewed regularly in light
of evolving science and animal protection measures" (European Parliament,
2010). Emphasis on the use of existing alternative techniques and the further
development of new methods is strengthened by requirements for project
evaluations, increased transparency, and, most importantly, the retrospective
assessment of all projects using NHPs and projects involving procedures clas
sified as "severe" (Article 39).

4

Ending Cosmetics Animal Testing: 20 Years and Counting...

Nowhere is the importance of procedural access points and the willingness of
legislators to respond to the wishes of citizens more visibly demonstrated than
in the 20-year struggle to end animal testing of cosmetics and the sale of newly
animal-tested cosmetics ingredients in the EU. Without detailing every one of
the (numerous) twists and turns it took to see the 2013 ban enter into force, one
hard-fought measure deserves special mention: the requirement for a full po
litical negotiation in the event of any attempt to delay implementation of the
final 2013 deadline. Although the sale ban had been agreed on in 1993 and was
due to be implemented in 1998, the EC was permitted, under the 6th Amend
ment to the Cosmetics Directive (European Commission, 1993), to delay it until
2000 and then to 2002, on the grounds that replacement tests were not fully
developed. The delays were agreed on through the comitology process, offer
ing a lower level of access than a full political debate. However, further delays
were not permitted beyond the 2002 deadline, by which time a new legislative
proposal was published, triggering a full political negotiation before further
delays could be adopted.
The point of interest for campaigners is that within the 7th Amendment
(European Commission, 2003), new wording deliberately prevented any fur
ther delay without a legislative proposal being debated and voted upon by
the European Parliament and Council. The 2009 phase of the sale ban gave no
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provision for any kind of delay, on any grounds; and the final 2013 phase could
only be delaye d by new legislation. Creating the requirement for another ac
cess point-a 2013 renegotiation in the event that animal tests had not been
replaced-was the key compromise that satisfied both industry and animal
advocates. As the 2013 deadline approached, the EC opted to implement the
ban and avoid any further accusations that they were ignoring the wishes of
citizens. However, nothing is safe until full animal replacement is achieved,
and although animal organizations rightly view an end to cosmetics animal
testing as a political objective, achievable in the absence of alternatives be
ing in place, loopholes putting our achievements at risk are relatively easily
disguised. Perceived ambiguities concerning the terms of the ban have led to
legal challenges, underlining the need for constant vigilance. Had the wording
of Article 13 of the Cosmetics Directive been tighter (European Commission,
2009, Regulation (Ec)1223/2009), we could have avoided the threat of further
challenges.
On the day the European Parliament's Environment Committee debated
their second reading position, a front-page article in the UK's Independent
newspaper revealed behind-the-scenes lobbying by a major company to en
sure ambiguity persisted, and loopholes were not closed (Woolf, 2002). The
article was handed to Members of the European Parliament (MEPs) and while
some unhelpful caveats remained, the final wording saw the Parliament suc
cessfully overcome opposition from EU Member States and adopt measures
that would ban animal testing for cosmetics, and phase in the ban on selling
newly animal-tested cosmetics ingredients (Osborn, 2002). The cosmetics cam
paign and resulting legislation also emphasize the importance of consensus
building around the need to replace animal tests. The 1993 legislation triggered
increased efforts to replace animal methods and resulted in valuable contribu
tions from industry, Member States, and the EC. EURL ECVAM became a world
leader in validating alternatives, and the EU entered the twenty-first century
expressing a clear aspiration to replace outdated, failing animal methods.

5

REACH, Chemical Testing and Transforming Toxicology

The political negotiation of Registration, Evaluation, Authorisation and Re
striction of Chemicals (REACH), the Eu Chemicals Regulation (European Com
mission, 2006, Regulation (Ee) 1907/2006), forced stakeholders with different
aims to work together. A direct confrontation between industry (who favored
lower costs and regulatory burdens) and environmental groups (who called
for expensive animal testing and rigorous regulatory processes) left animal
advocates needing to tread carefully. However, the animal protection agenda
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was in no danger of being ignored. Calculations regarding the number of ani
mal tests that could be required by REACH-varying initially from 9.5 million
to 45.8 million (Institute for Environment and Health, 2001)-hit the head
lines; but there was an associated danger of animal welfare arguments being
co-opted by those simply wanting to reduce test costs. Politicians, more likely
to favor environmental concerns, were also those with the strongest policies on
animal protection; so a simple alignment with industry would have been high
ly problematic. Policies on data-sharing and transparency helped to forge links
between animal and environmental groups, but the most important develop
ment concerned the recognition that animal tests represented outdated sci
ence. As the discussions progressed, all players acknowledged that because the
future EU chemicals policy would be dependent on animal testing, it was im
possible to ignore either the animal welfare or scientific case for replacement.
Between 2001 and 2003 the tone of the European debate around toxicity
testing shifted. Publication of the ECEAE report, The Way Forward: A Non
Animal Testing Strategy for Chemicals (European Coalition to End Animal Ex
periments, 2003) was pivotal in defining the debate for decades to come. The
EcEAE argued that in an ideal situation, there would be no need to make a
choice between saving animals and protecting people. Replacing animal tests
provided a win/win solution. New non-animal tests could be better, cheaper,
and faster; and reliance on outdated animal tests would waste money and po
tentially confound those seeking decisive regulatory action. The conclusion
of the REACH negotiation in 2006 saw several meaningful animal welfare de
mands enshrined in legislation, with "promotion of alternative methods for
assessment of hazards of substances" becoming one of three objectives of the
legislation, listed in Article 1.
The political shift, which started with tentative statements from radical
Green Party politicians about the scientific need to replace animal tests, grew
to represent the mainstream view of the European Parliament and Council. By
the time MEPs of the center left had picked up the new rhetoric, a convincing
case had been made, and at first reading the European Parliament's environ
mental committee voted for an entirely non-animal testing approach under
REACH (Committee on the Environment, Public Health and Food Safety, 2005),
marking a significant call on all concerned to do more to replace animal tests.
Again, consensus around the need to replace animal methods achieved over
whelming support, and a central requirement of REACH is that animal testing
should only be carried out as a last resort.
The legislative gains enshrined in REACH built on past success concerning
replacement, including the application and development of 3R methods, as
mentioned in Directive 1986/609/EEC and required by the 1993 Cosmetics

Kathrin Herrmann and Kimberley Jayne - 978-90-04-39119-2
Downloaded from Brill.com11/11/2019 09:57:0BPM
via free access

159

POLITICAL CAMPAIGNING

Directive, and broke new ground by requiring rapid updating of legislation in
response to new methods becoming available. What these legal requirements
did not do was ensure that regulators and the European Chemicals Agency
(ECHA) apply the rules without constant pressure from campaigners, culmi
nating in several rulings against ECHA by the EU Ombudsman for failing to
meet regulatory requirements relating to avoidance of animal testing (PETA
UK, 2014; ECHA, 2015).

6

2001-2003:

Paradigm Shift Meets Parliament

The fifth term of the European Parliament (1999-2004) saw MEPs from across
the political divide join forces to push the replacement agenda through leg
islative debates, Reports and Parliamentary Questions. The fact that REACH
and the 7th Amendment to the Cosmetics Directive were on the Parliamen
tary agenda at the same time, and the EC was working to revise Directive
1986/609/EEC, made for more urgency. The EC/Industry collaboration, the Eu
ropean Partnership for Alternatives to Animal Testing (EPAA), was established
during this period, providing a forum in which companies could combine re
sources and expertise and demonstrate their commitment to implementation
of the 3Rs. The EPAA has achieved a number of notable successes, including
the study that informed changes to Annex VIII of REACH, ensuring that acute
toxicity studies, using the dermal route, can be waived in most circumstances
(EPAA, 2014).
In the midst of these political activities, the need for an accelerated
process to achieve international adoption of the Organisation for Economic
Co-operation and Development (OECD) Test Guidelines was recognized. The
International Coalition for Animal Protection in OECD Programs (ICAPO)
was formed (ICAPO, n.d.), allowing scientific experts working for interna
tional animal protection organizations, to participate in global efforts to
implement the 3Rs. The structure of ICAPO has, helpfully, required organiza
tions to maintain a single point of contact with the OECD and to collaborate
with each other. To complete the picture, EU Framework Program (FP) fund
ing decisions were taking a positive direction. Under FP6 (2002-2006), 21
projects to advance animal-free methods were funded, with a total of over
€63 million, and contained wording-thanks to the European Parliament
concerning the need to replace toxicity testing on animals (European Parlia
ment, 2002, Decision 1513/2002/EC). In this context, during the first years of
the twenty-first century, several advances were made, the results of which are
still playing out.
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7

Post-2010/63/EU: E U Lobbying and the Global Challenge

During the negotiation of Directive 2010/63/EU, information about the in
tentions of industry and the animal user community crept into the pub
lic domain. In the absence of replacement science successfully displacing
animal research, the future for animals could look very bleak indeed. In
2009, the UK House of Lords Select Committee on the European Union Sub
Committee D (Environment and Agriculture) held an inquiry and reported
to Parliament (HL 164 2009-2010). During the evidence sessions, questions
were posed about the potential for higher welfare standards in the Eu to
drive animal use abroad. While there was clear evidence that an EU re
search base holds several advantages for companies, several contributions
were worrying.
Evidence presented in the Memorandum by the Bioscience Sector (House
of Lords, 2009) notes the existence of "substantial competition from coun
tries, such as China, India, and Singapore in developing infrastructure to
undertake animal research, which includes not just routine toxicity tests but
also R & D" (p. 21); and states that "commercial investment [is] increasing
faster in countries outside the EU, such as the us, China and India" (p. 19).
During the oral evidence session, industry representatives described the
experience that "most major pharmaceutical companies are now investing
in Asia" (p. 43), with decisions being "influenced very strongly, particularly,
by access to non-human primates and developing the Asian market with
particular reference to China" (p. 43). One representative went on to de
scribe new facilities in Shanghai, which will focus on cancer research and
collaboration with a Chinese institution dedicated to constructing a specific
NHP facility.
The view that higher EU welfare standards are unlikely to contribute in
the short term to this shift is broadly supported, but the expectation of in
dustry is that growing markets and longer-term projections are contributing
to the expansion of animal facilities in countries not governed by EU stan
dards. The fear is not so much that companies will fail to keep pace with,
for example, EU standards of housing and care, but that in countries with
less rigorous legislation, less attention will be paid to severity limits, report
ing, and transparency. This global expansion does not, however, mean that
EU political campaigning is any less important. Increased scientific scrutiny,
such as that required by European legislation, along with funding for the de
velopment of alternatives, is driving global change. We cannot protect NHP
in Chinese research facilities, but we can hold the science behind NHP use to
account.
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The EC's Scientific Committee Opinions on NHP Use, 2009 and 2017

Use of NHPs in the EU is highly controversial. Years of public campaigning has
raised awareness of NHP suffering and sentience (Jennings, 2010); and the 2007
European Parliamentary Declaration, which called for a timetable for replac
ing all use of NHPs (European Parliament, 2007, P6_TA(2007)0407) led to the
inclusion of proposals to limit NHP use in the EC's legislative proposal of 2008.
Alongside this, the EC requested a series of Opinions from its scientific com
mittees concerning the potential to replace NHP use.
Animal advocates have, repeatedly, found the process by which the Opinions
have been formulated frustrating and biased. Contributors tend to be NHP users
rather than biomedical researchers who use non-animal methods. In the most
recent Opinion, released by the Scientific Committee on Health Environmental
and Emerging Risks (SCHEER) (SCHEER, 2017), the Committee argues in favor
of continued NHP use, while failing to acknowledge key reviews on the ineffec
tiveness of NHPs as a model for humans or reviews on advances in alternative
animal-free methods. Nevertheless, the Committee made a handful of recom
mendations, including that systematic reviews should be undertaken and the
"psychological effect" on NHP s should be better assessed (though this latter rec
ommendation could lead to further research on NHP laboratory welfare).

g

The Citizens' Initiative: Stop Vivisection

In this context, it is not hard to see why campaigners have continued to call
for an outright ban on all animal experiments. The Lisbon Treaty of 2009 in
troduced a process by which European citizens can initiate activity by the EC,
including proposals for new legislation, if a petition receives one million sig
natures collected in seven EU Member States within one year (the European
Citizens' Initiative, European Commission, 2011). The third successful Citizens'
Initiative, Stop Vivisection, registered in 2012, called on the EC to "abrogate di
rective 2010/63/EU on the protection of animals used for scientific purposes
and to present a new proposal that does away with animal experimentation
and instead makes compulsory the use-in biomedical and toxicological re
search-of data directly relevant for the human species" (European Citizens'
Initiative, 2016). The Citizens' Initiative demonstrated, again, EU-wide support
for ending the use of animals in research and testing, raised awareness among
policy makers, and generated new commitments from the EC. The European
Parliament hearing on the Citizens' Initiative gave MEPs the opportunity to lis
ten to arguments first-hand and question experts (European Parliament, 2015).
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The EC's 2015 Communication responding to Stop Vivisection (C(2015) 3773)
identified four action points:
(1) Acceleration of progress in the 3Rs through knowledge sharing
(2) Development, validation, and implementation of new alternative
approaches
(3) Enforcement of compliance with the 3Rs principle and alignment of relevant sector legislation
(4) Engagement in a dialogue with the scientific community.
The EC's response concluded by welcoming "the mobilisation of citizens in
support of animal welfare" stating that "the Citizens' Initiative has provided
an opportunity to critically examine how the EU can reinforce its efforts in
moving from animal to non-animal based research and testing" (European
Commission, 2015, p. 10). However, there is no evidence that relevant decision
making bodies, such as Member State National Committees, referred to in Di
rective 2010/63/EU, are making the necessary adjustments.
Action 4 committed the EC to organize a scientific conference titled Non
Animal Approaches - The Way Forward, which, although supported by a
wider-than-usual audience of stakeholders, was boycotted by the organizers
of the Stop Vivisection Citizens' Initiative, who later made a complaint to the
EU Ombudsman, considering that "the [European] Commission had given
an inadequate response to the initiative and the detailed proposals put for
ward in the context of the initiative". The Ombudsman rejected the complaint
(Eu Ombudsman, 2017); but the substance of the Initiative remains active,
and is an important milestone for policy makers at all levels of EU decision
making.

10

Conclusion

Scientific progress does not necessarily equate to changes in practice, in public
policy, or in legislation; but political progress can drive science. For this rea
son alone, effective political strategies are essential. The paradigm shift can
be accelerated by improvements in transparency, reporting, and protection of
animals as well as by increasing levels of scientific scrutiny, funding, and po
litical will. Experience gained at the EU level demonstrates that when public
opinion-backed by convincing evidence and practical proposals-can be ef
fectively presented, policy makers are required to balance competing interests
and promote workable solutions. In the field of research on animals, this often
results in increased efforts to replace animal experiments. Public opinion sur
veys indicate that legislators have not yet created laws that adequately address
citizens' concerns; but continuing public and political pressure has ensured
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new initiatives are likely and further access points, in terms of influencing the
regulatory agenda, are open to advocacy groups.
Developing a coherent political strategy on the basis of either science or ani
mal protection alone is fraught with difficulties. Heated debate, and regulatory
systems attempting to balance animal suffering with expected outcomes have
forced animal advocates into the scientific arena and scientists to respond to
welfare requirements. Those campaigning for a paradigm shift are gaining sci
entific weight and credibility, and new technologies are unstoppable.
So, what will end the use of animals in experiments in the shortest pos
sible time? Using the experience gained over the past twenty years of EU-level
campaigning, it seems sensible to accept that widely different approaches and
organizations all have their place. Welfare advocates who work only with in
dustry can achieve a great deal; the promoters of the Citizens' Initiative, Stop
Vivisection, caused the E C to set new goals and attempt to create consensus
between stakeholders holding radically different views, and EU-level coali
tions of national advocacy groups, together with a handful of international
organizations, through dogged scrutiny of implementation procedures, main
tain public and political pressure. The need for legislators and regulators to
demonstrate a willingness to hear the views of a range of stakeholders has al
lowed animal advocates to find a voice at all levels of political processes and to
work with other campaign groups, industry, and academia to promote shared
objectives.
The experience of political campaigning described above is offered in the
hope that the paradigm shift happens sooner rather than later. The follow
ing overview of the points described above and lessons learned may also be
of use:

-

Political Camp aigning:
Make use of all procedural access points, remembering that early interven
tion works best.
Work across political divides and with all stakeholders to understand the
full range of opinions and differing viewpoints.
Join expert groups, share expertise, and try to avoid duplicating the work of
other, similar organizations.
Understand the agenda of your opponents and check the meaning of word
ing that seems unclear. Loopholes can be avoided if spotted early enough.
Create new access points. Always work for regular reviews, reports, and fur
ther studies.
Find ways to increase transparency. From ensuring all animals are count
ed to sophisticated prospective and retrospective reviews, transparency is
essential.
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Appreciate the work of consensus-based entities. Where there is consensus,
meaningful progress should be achievable.
Amplifying Our Message:
Animal advocacy organizations working together are more likely to suc
ceed. We have seen this through I CAPO and in the political arena. Sharing
material early on and avoiding duplication is more likely to ensure initia
tives are successful.
Formulating joint positions with other organizations, such as environment,
health, patient, and industry groups, amplifies our message.
Coalitions and umbrella groups are helpful but need to demonstrate the ex
tent of their supporter base, for example, by directly linking politicians with
national organizations and the citizens they represent.
The question of global versus national or regional campaigning answers itself.
We need to work at every level, in every forum, using all peaceful, evidence
based, effective means available to us. From handing out leaflets in the street
to funding studies by researchers to expose failing animal models of dis
ease, every contribution is valuable and is helping to achieve the paradigm
shift.
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